1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global VNA & PACS Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 VNA
1.2.3 PACS
1.3 Market by Application
1.3.1 Global VNA & PACS Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Diagnostic Imaging Center
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global VNA & PACS Market Perspective (2017-2028)
2.2 VNA & PACS Growth Trends by Region
2.2.1 VNA & PACS Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 VNA & PACS Historic Market Size by Region (2017-2022)
2.2.3 VNA & PACS Forecasted Market Size by Region (2023-2028)
2.3 VNA & PACS Market Dynamics
2.3.1 VNA & PACS Industry Trends
2.3.2 VNA & PACS Market Drivers
2.3.3 VNA & PACS Market Challenges
2.3.4 VNA & PACS Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top VNA & PACS Players by Revenue
3.1.1 Global Top VNA & PACS Players by Revenue (2017-2022)
3.1.2 Global VNA & PACS Revenue Market Share by Players (2017-2022)
3.2 Global VNA & PACS Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by VNA & PACS Revenue
3.4 Global VNA & PACS Market Concentration Ratio
3.4.1 Global VNA & PACS Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by VNA & PACS Revenue in 2021
3.5 VNA & PACS Key Players Head office and Area Served
3.6 Key Players VNA & PACS Product Solution and Service
3.7 Date of Enter into VNA & PACS Market
3.8 Mergers & Acquisitions, Expansion Plans 4 VNA & PACS Breakdown Data by Type
4.1 Global VNA & PACS Historic Market Size by Type (2017-2022)
4.2 Global VNA & PACS Forecasted Market Size by Type (2023-2028) 5 VNA & PACS Breakdown Data by Application
5.1 Global VNA & PACS Historic Market Size by Application (2017-2022)
5.2 Global VNA & PACS Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America VNA & PACS Market Size (2017-2028)
6.2 North America VNA & PACS Market Size by Type
6.2.1 North America VNA & PACS Market Size by Type (2017-2022)
6.2.2 North America VNA & PACS Market Size by Type (2023-2028)
6.2.3 North America VNA & PACS Market Share by Type (2017-2028)
6.3 North America VNA & PACS Market Size by Application
6.3.1 North America VNA & PACS Market Size by Application (2017-2022)
6.3.2 North America VNA & PACS Market Size by Application (2023-2028)
6.3.3 North America VNA & PACS Market Share by Application (2017-2028)
6.4 North America VNA & PACS Market Size by Country
6.4.1 North America VNA & PACS Market Size by Country (2017-2022)
6.4.2 North America VNA & PACS Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada 7 Europe
7.1 Europe VNA & PACS Market Size (2017-2028)
7.2 Europe VNA & PACS Market Size by Type
7.2.1 Europe VNA & PACS Market Size by Type (2017-2022)
7.2.2 Europe VNA & PACS Market Size by Type (2023-2028)
7.2.3 Europe VNA & PACS Market Share by Type (2017-2028)
7.3 Europe VNA & PACS Market Size by Application
7.3.1 Europe VNA & PACS Market Size by Application (2017-2022)
7.3.2 Europe VNA & PACS Market Size by Application (2023-2028)
7.3.3 Europe VNA & PACS Market Share by Application (2017-2028)
7.4 Europe VNA & PACS Market Size by Country
7.4.1 Europe VNA & PACS Market Size by Country (2017-2022)
7.4.2 Europe VNA & PACS Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific VNA & PACS Market Size (2017-2028)
8.2 Asia-Pacific VNA & PACS Market Size by Type
8.2.1 Asia-Pacific VNA & PACS Market Size by Type (2017-2022)
8.2.2 Asia-Pacific VNA & PACS Market Size by Type (2023-2028)
8.2.3 Asia-Pacific VNA & PACS Market Share by Type (2017-2028)
8.3 Asia-Pacific VNA & PACS Market Size by Application
8.3.1 Asia-Pacific VNA & PACS Market Size by Application (2017-2022)
8.3.2 Asia-Pacific VNA & PACS Market Size by Application (2023-2028)
8.3.3 Asia-Pacific VNA & PACS Market Share by Application (2017-2028)
8.4 Asia-Pacific VNA & PACS Market Size by Region
8.4.1 Asia-Pacific VNA & PACS Market Size by Region (2017-2022)
8.4.2 Asia-Pacific VNA & PACS Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia 9 Latin America
9.1 Latin America VNA & PACS Market Size (2017-2028)
9.2 Latin America VNA & PACS Market Size by Type
9.2.1 Latin America VNA & PACS Market Size by Type (2017-2022)
9.2.2 Latin America VNA & PACS Market Size by Type (2023-2028)
9.2.3 Latin America VNA & PACS Market Share by Type (2017-2028)
9.3 Latin America VNA & PACS Market Size by Application
9.3.1 Latin America VNA & PACS Market Size by Application (2017-2022)
9.3.2 Latin America VNA & PACS Market Size by Application (2023-2028)
9.3.3 Latin America VNA & PACS Market Share by Application (2017-2028)
9.4 Latin America VNA & PACS Market Size by Country
9.4.1 Latin America VNA & PACS Market Size by Country (2017-2022)
9.4.2 Latin America VNA & PACS Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil 10 Middle East & Africa
10.1 Middle East & Africa VNA & PACS Market Size (2017-2028)
10.2 Middle East & Africa VNA & PACS Market Size by Type
10.2.1 Middle East & Africa VNA & PACS Market Size by Type (2017-2022)
10.2.2 Middle East & Africa VNA & PACS Market Size by Type (2023-2028)
10.2.3 Middle East & Africa VNA & PACS Market Share by Type (2017-2028)
10.3 Middle East & Africa VNA & PACS Market Size by Application
10.3.1 Middle East & Africa VNA & PACS Market Size by Application (2017-2022)
10.3.2 Middle East & Africa VNA & PACS Market Size by Application (2023-2028)
10.3.3 Middle East & Africa VNA & PACS Market Share by Application (2017-2028)
10.4 Middle East & Africa VNA & PACS Market Size by Country
10.4.1 Middle East & Africa VNA & PACS Market Size by Country (2017-2022)
10.4.2 Middle East & Africa VNA & PACS Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE 11 Key Players Profiles
11.1 Agfa HealthCare
11.1.1 Agfa HealthCare Company Details
11.1.2 Agfa HealthCare Business Overview
11.1.3 Agfa HealthCare VNA & PACS Introduction
11.1.4 Agfa HealthCare Revenue in VNA & PACS Business (2017-2022)
11.1.5 Agfa HealthCare Recent Developments
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare VNA & PACS Introduction
11.2.4 GE Healthcare Revenue in VNA & PACS Business (2017-2022)
11.2.5 GE Healthcare Recent Developments
11.3 INFINITT Healthcare CO.
11.3.1 INFINITT Healthcare CO. Company Details
11.3.2 INFINITT Healthcare CO. Business Overview
11.3.3 INFINITT Healthcare CO. VNA & PACS Introduction
11.3.4 INFINITT Healthcare CO. Revenue in VNA & PACS Business (2017-2022)
11.3.5 INFINITT Healthcare CO. Recent Developments
11.4 Mach7 Technologies
11.4.1 Mach7 Technologies Company Details
11.4.2 Mach7 Technologies Business Overview
11.4.3 Mach7 Technologies VNA & PACS Introduction
11.4.4 Mach7 Technologies Revenue in VNA & PACS Business (2017-2022)
11.4.5 Mach7 Technologies Recent Developments
11.5 Merge Healthcare Inc.
11.5.1 Merge Healthcare Inc. Company Details
11.5.2 Merge Healthcare Inc. Business Overview
11.5.3 Merge Healthcare Inc. VNA & PACS Introduction
11.5.4 Merge Healthcare Inc. Revenue in VNA & PACS Business (2017-2022)
11.5.5 Merge Healthcare Inc. Recent Developments
11.6 Sectra AB
11.6.1 Sectra AB Company Details
11.6.2 Sectra AB Business Overview
11.6.3 Sectra AB VNA & PACS Introduction
11.6.4 Sectra AB Revenue in VNA & PACS Business (2017-2022)
11.6.5 Sectra AB Recent Developments
11.7 BridgeHead Software Limited
11.7.1 BridgeHead Software Limited Company Details
11.7.2 BridgeHead Software Limited Business Overview
11.7.3 BridgeHead Software Limited VNA & PACS Introduction
11.7.4 BridgeHead Software Limited Revenue in VNA & PACS Business (2017-2022)
11.7.5 BridgeHead Software Limited Recent Developments
11.8 Carestream Health Inc.
11.8.1 Carestream Health Inc. Company Details
11.8.2 Carestream Health Inc. Business Overview
11.8.3 Carestream Health Inc. VNA & PACS Introduction
11.8.4 Carestream Health Inc. Revenue in VNA & PACS Business (2017-2022)
11.8.5 Carestream Health Inc. Recent Developments
11.9 Fujifilm Medical Systems U.S.A.
11.9.1 Fujifilm Medical Systems U.S.A. Company Details
11.9.2 Fujifilm Medical Systems U.S.A. Business Overview
11.9.3 Fujifilm Medical Systems U.S.A. VNA & PACS Introduction
11.9.4 Fujifilm Medical Systems U.S.A. Revenue in VNA & PACS Business (2017-2022)
11.9.5 Fujifilm Medical Systems U.S.A. Recent Developments
11.10 Hyland Software Inc.
11.10.1 Hyland Software Inc. Company Details
11.10.2 Hyland Software Inc. Business Overview
11.10.3 Hyland Software Inc. VNA & PACS Introduction
11.10.4 Hyland Software Inc. Revenue in VNA & PACS Business (2017-2022)
11.10.5 Hyland Software Inc. Recent Developments
11.11 Koninklijke Philips N.V.
11.11.1 Koninklijke Philips N.V. Company Details
11.11.2 Koninklijke Philips N.V. Business Overview
11.11.3 Koninklijke Philips N.V. VNA & PACS Introduction
11.11.4 Koninklijke Philips N.V. Revenue in VNA & PACS Business (2017-2022)
11.11.5 Koninklijke Philips N.V. Recent Developments
11.12 McKesson Corporation
11.12.1 McKesson Corporation Company Details
11.12.2 McKesson Corporation Business Overview
11.12.3 McKesson Corporation VNA & PACS Introduction
11.12.4 McKesson Corporation Revenue in VNA & PACS Business (2017-2022)
11.12.5 McKesson Corporation Recent Developments
11.13 Novarad Corporation
11.13.1 Novarad Corporation Company Details
11.13.2 Novarad Corporation Business Overview
11.13.3 Novarad Corporation VNA & PACS Introduction
11.13.4 Novarad Corporation Revenue in VNA & PACS Business (2017-2022)
11.13.5 Novarad Corporation Recent Developments
11.14 Siemens Healthineers
11.14.1 Siemens Healthineers Company Details
11.14.2 Siemens Healthineers Business Overview
11.14.3 Siemens Healthineers VNA & PACS Introduction
11.14.4 Siemens Healthineers Revenue in VNA & PACS Business (2017-2022)
11.14.5 Siemens Healthineers Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
